ABI-007
| ABI-007 | |
|---|---|
| Term | ABI-007 |
| Short definition | ABI-007 - A form of the cancer drug paclitaxel, used alone or with other drugs to treat certain types of breast cancer, non-small cell lung cancer, and pancreatic cancer. ABI-007 may have fewer side effects and work better than other forms of paclitaxel. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
ABI-007 - A form of the cancer drug paclitaxel, used alone or with other drugs to treat certain types of breast cancer, non-small cell lung cancer, and pancreatic cancer. ABI-007 may have fewer side effects and work better than other forms of paclitaxel. It is also being studied in the treatment of other types of cancer. ABI-007 stops cancer cells from growing and dividing and can kill them. It's a kind of taxane. Also referred to as Abraxane, nanoparticle paclitaxel, paclitaxel albumin stabilized nanoparticle formulation, and protein-bound paclitaxel
External links
- Medical encyclopedia article on ABI-007
- Wikipedia's article - ABI-007
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski